Literature DB >> 23430894

Generation of a human neuronal stable cell model for niemann-pick C disease by RNA interference.

Laura Rodríguez-Pascau1, Maria Josep Coll, Josefina Casas, Lluïsa Vilageliu, Daniel Grinberg.   

Abstract

Niemann-Pick type C (NPC) disease is a fatal autosomal recessive neurodegenerative disorder caused, most commonly, by mutations in the NPC1 gene. At the cellular level, the disease is characterized by the storage of multiple lipids in the endosomal-lysosomal system, including free cholesterol, glycosphingolipids, sphingomyelin and the catabolic product of sphingolipids, sphingosine. Therapeutic options for NPC disease are relatively limited. One drawback for the development of novel therapies is the lack of suitable human neuronal cell models. In this work, a stable SH-SY5Y cell model for NPC disease was generated using short hairpin RNAs. An inhibition of the NPC1 expression of around 90% was obtained at the RNA level. The NPC1 knockdown was confirmed at the protein level. To characterize the stable cell line generated, cholesterol levels were analyzed in the NPC1-knockdown SH-SY5Y cells by filipin staining and gas chromatography-mass spectrometry. A characteristic NPC pattern and a twofold increase of the free cholesterol levels, related to intact SH-SY5Y cells, were found. Moreover, sphingolipids were analyzed by liquid chromatography-mass spectrometry and an increase in ganglioside GM2 levels was observed. The stable NPC1-knockdown SH-SY5Y cell line generated in the present study provides a human neuronal cell model for this lethal disease that could be a valuable tool for the study of future therapeutic approaches.

Entities:  

Year:  2011        PMID: 23430894      PMCID: PMC3509875          DOI: 10.1007/8904_2011_64

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  37 in total

1.  Spatial and temporal distribution of intracellular free cholesterol in brains of a Niemann-Pick type C mouse model showing hyperphosphorylated tau protein. Implications for Alzheimer's disease.

Authors:  Stephanie Treiber-Held; Roland Distl; Volker Meske; Frank Albert; Thomas G Ohm
Journal:  J Pathol       Date:  2003-05       Impact factor: 7.996

2.  Cholesterol accumulates in cell bodies, but is decreased in distal axons, of Niemann-Pick C1-deficient neurons.

Authors:  Barbara Karten; Dennis E Vance; Robert B Campenot; Jean E Vance
Journal:  J Neurochem       Date:  2002-12       Impact factor: 5.372

3.  Cholesterol is sequestered in the brains of mice with Niemann-Pick type C disease but turnover is increased.

Authors:  C Xie; D K Burns; S D Turley; J M Dietschy
Journal:  J Neuropathol Exp Neurol       Date:  2000-12       Impact factor: 3.685

4.  Critical role for glycosphingolipids in Niemann-Pick disease type C.

Authors:  M Zervas; K L Somers; M A Thrall; S U Walkley
Journal:  Curr Biol       Date:  2001-08-21       Impact factor: 10.834

5.  Oxidative stress activates the c-Abl/p73 proapoptotic pathway in Niemann-Pick type C neurons.

Authors:  Andres Klein; Carola Maldonado; Lina M Vargas; Marcela Gonzalez; Fermín Robledo; Karen Perez de Arce; Francisco J Muñoz; Claudio Hetz; Alejandra R Alvarez; Silvana Zanlungo
Journal:  Neurobiol Dis       Date:  2010-09-29       Impact factor: 5.996

6.  Identification of HE1 as the second gene of Niemann-Pick C disease.

Authors:  S Naureckiene; D E Sleat; H Lackland; A Fensom; M T Vanier; R Wattiaux; M Jadot; P Lobel
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

7.  NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of low density lipoprotein cholesterol-derived oxysterols.

Authors:  Andrey Frolov; Sarah E Zielinski; Jan R Crowley; Nicole Dudley-Rucker; Jean E Schaffer; Daniel S Ory
Journal:  J Biol Chem       Date:  2003-04-28       Impact factor: 5.157

8.  Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport.

Authors:  David E Sleat; Jennifer A Wiseman; Mukarram El-Banna; Sandy M Price; Lucie Verot; Michael M Shen; G Stephen Tint; Marie T Vanier; Steven U Walkley; Peter Lobel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

9.  A novel cholesterol stain reveals early neuronal cholesterol accumulation in the Niemann-Pick type C1 mouse brain.

Authors:  Patrick C Reid; Naomi Sakashita; Shigeki Sugii; Yoshiko Ohno-Iwashita; Yukiko Shimada; William F Hickey; Ta-Yuan Chang
Journal:  J Lipid Res       Date:  2004-01-01       Impact factor: 5.922

10.  Cholesterol pathways affected by small molecules that decrease sterol levels in Niemann-Pick type C mutant cells.

Authors:  Madalina Rujoi; Nina H Pipalia; Frederick R Maxfield
Journal:  PLoS One       Date:  2010-09-21       Impact factor: 3.240

View more
  5 in total

1.  A human neuronal model of Niemann Pick C disease developed from stem cells isolated from patient's skin.

Authors:  Natascha Bergamin; Andrea Dardis; Antonio Beltrami; Daniela Cesselli; Silvia Rigo; Stefania Zampieri; Rossana Domenis; Bruno Bembi; Carlo Alberto Beltrami
Journal:  Orphanet J Rare Dis       Date:  2013-02-21       Impact factor: 4.123

2.  Niemann-Pick Disease Type C: Induced Pluripotent Stem Cell-Derived Neuronal Cells for Modeling Neural Disease and Evaluating Drug Efficacy.

Authors:  Daozhan Yu; Manju Swaroop; Mengqiao Wang; Ulrich Baxa; Rongze Yang; Yiping Yan; Turhan Coksaygan; Louis DeTolla; Juan J Marugan; Christopher P Austin; John C McKew; Da-Wei Gong; Wei Zheng
Journal:  J Biomol Screen       Date:  2014-06-06

Review 3.  Understanding and Treating Niemann-Pick Type C Disease: Models Matter.

Authors:  Valentina Pallottini; Frank W Pfrieger
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

4.  Niemann-Pick type C1 patient-specific induced pluripotent stem cells display disease specific hallmarks.

Authors:  Michaela Trilck; Rayk Hübner; Philip Seibler; Christine Klein; Arndt Rolfs; Moritz J Frech
Journal:  Orphanet J Rare Dis       Date:  2013-09-18       Impact factor: 4.123

5.  Modeling Niemann-Pick disease type C in a human haploid cell line allows for patient variant characterization and clinical interpretation.

Authors:  Steven Erwood; Reid A Brewer; Teija M I Bily; Eleonora Maino; Liangchi Zhou; Ronald D Cohn; Evgueni A Ivakine
Journal:  Genome Res       Date:  2019-11-21       Impact factor: 9.043

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.